Oneness Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 22.19 million compared to TWD 20.08 million a year ago. Net loss was TWD 264.68 million compared to net income of TWD 388.54 million a year ago.

Basic loss per share from continuing operations was TWD 0.5977 compared to basic earnings per share from continuing operations of TWD 0.8877 a year ago. Diluted loss per share from continuing operations was TWD 0.5977 compared to diluted earnings per share from continuing operations of TWD 0.8701 a year ago.